Michael G Erickson sold $3.4M of IDXX
Executive Vice President at IDEXX LABORATORIES INC /DE. 5,371 shares at an average of $627.38, traded Feb 17, 2026, filed Feb 19, 2026.
Score components
- +15RoleOfficer
- +25Trade size$3.4M at market
- +10Share of holdings soldSold 30% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000874716-26-000033, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 17, 2026 | MOption exercise Common Stock | +1,191 | $141.60 | $169k | 13,884 | Feb 19, 2026 |
| Feb 17, 2026 | MOption exercise Common Stock | +4,180 | $178.26 | $745k | 18,064 | Feb 19, 2026 |
| Feb 17, 2026 | SOpen-market sale Common Stock | -456 | $623.76 | $284k | 17,608 | Feb 19, 2026 |
| Feb 17, 2026 | SOpen-market sale Common Stock | -204 | $625.24 | $128k | 17,404 | Feb 19, 2026 |
| Feb 17, 2026 | SOpen-market sale Common Stock | -1,288 | $626.26 | $807k | 16,116 | Feb 19, 2026 |
| Feb 17, 2026 | SOpen-market sale Common Stock | -2,694 | $628.22 | $1.7M | 13,422 | Feb 19, 2026 |
| Feb 17, 2026 | SOpen-market sale Common Stock | -689 | $629.09 | $433k | 12,733 | Feb 19, 2026 |
| Feb 17, 2026 | SOpen-market sale Common Stock | -40 | $629.86 | $25k | 12,693 | Feb 19, 2026 |
| Feb 19, 2026 | MOption exercise Common Stock | +719 | $141.60 | $102k | 13,412 | Feb 19, 2026 |
| Feb 19, 2026 | MOption exercise Common Stock | +817 | $178.26 | $146k | 14,229 | Feb 19, 2026 |
| Feb 19, 2026 | MOption exercise Common Stock | +483 | $206.94 | $100k | 14,712 | Feb 19, 2026 |
| Feb 19, 2026 | MOption exercise Common Stock | +183 | $544.08 | $100k | 14,895 | Feb 19, 2026 |
| Feb 19, 2026 | MOption exercise Common Stock | +197 | $505.53 | $100k | 15,092 | Feb 19, 2026 |
| Feb 17, 2026 | MOption exercise Non-Qualified Stock Option (right-to-buy)derivative | -1,191 | $0.00 | $0 | 0 | Feb 19, 2026 |
| Feb 17, 2026 | MOption exercise Non-Qualified Stock Option (right-to-buy)derivative | -4,180 | $0.00 | $0 | 0 | Feb 19, 2026 |
| Feb 19, 2026 | MOption exercise Incentive Stock Option (right-to-buy)derivative | -719 | $0.00 | $0 | 0 | Feb 19, 2026 |
| Feb 19, 2026 | MOption exercise Incentive Stock Option (right-to-buy)derivative | -817 | $0.00 | $0 | 0 | Feb 19, 2026 |
| Feb 19, 2026 | MOption exercise Incentive Stock Option (right-to-buy)derivative | -483 | $0.00 | $0 | 0 | Feb 19, 2026 |
| Feb 19, 2026 | MOption exercise Incentive Stock Option (right-to-buy)derivative | -183 | $0.00 | $0 | 0 | Feb 19, 2026 |
| Feb 19, 2026 | MOption exercise Incentive Stock Option (right-to-buy)derivative | -197 | $0.00 | $0 | 0 | Feb 19, 2026 |
Related signals
Other insiders at IDEXX LABORATORIES INC /DE and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | IDXXsell IDEXX LABORATORIES INC /DE | Lawrence D Kingsley director | $1.2M 2,203 shares | -19% | |
| 55Moderate | IDEXX LABORATORIES INC /DE | Nimrata Hunt Executive Vice President | $1.1M 1,758 shares | -9% | |
| 55Moderate | IDEXX LABORATORIES INC /DE | Jonathan Jay Mazelsky President and CEO | $15M 23,326 shares | -22% | |
| 60Notable | IDEXX LABORATORIES INC /DE | Nimrata Hunt Executive Vice President | $1.8M 2,693 shares | -12% | |
| 59Moderate | IDEXX LABORATORIES INC /DE | Sophie V. Vandebroek director | $920k 1,464 shares | -69% | |
| 60Notable | IDEXX LABORATORIES INC /DE | George Fennell Executive Vice President | $7.3M 11,345 shares | -54% | |
| 35Weak | IDXXsell IDEXX LABORATORIES INC /DE | Nimrata Hunt Executive Vice President | $6.6M 9,425 shares | -31% | |
| 60Notable | IDEXX LABORATORIES INC /DE | M Anne Szostak director | $1.4M 2,187 shares | -89% | |
| 43Moderate | IDEXX LABORATORIES INC /DE | Michael G Erickson Executive Vice President | $264k 406 shares | -3% | |
| 37Weak | IDEXX LABORATORIES INC /DE | Nimrata Hunt Executive Vice President | $788k 1,200 shares | -7% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.